423 related articles for article (PubMed ID: 31087035)
1. Friend retrovirus studies reveal complex interactions between intrinsic, innate and adaptive immunity.
Dittmer U; Sutter K; Kassiotis G; Zelinskyy G; Bánki Z; Stoiber H; Santiago ML; Hasenkrug KJ
FEMS Microbiol Rev; 2019 Sep; 43(5):435-456. PubMed ID: 31087035
[TBL] [Abstract][Full Text] [Related]
2. Ribonuclease L is not critical for innate restriction and adaptive immunity against Friend retrovirus infection.
Li SX; Barrett BS; Harper MS; Heilman KJ; Halemano K; Steele AK; Guo K; Silverman RH; Santiago ML
Virology; 2013 Aug; 443(1):134-42. PubMed ID: 23725696
[TBL] [Abstract][Full Text] [Related]
3. A Combination of Anti-PD-L1 Treatment and Therapeutic Vaccination Facilitates Improved Retroviral Clearance via Reactivation of Highly Exhausted T Cells.
Knuschke T; Kollenda S; Wenzek C; Zelinskyy G; Steinbach P; Dittmer U; Buer J; Epple M; Westendorf AM
mBio; 2021 Feb; 12(1):. PubMed ID: 33531395
[TBL] [Abstract][Full Text] [Related]
4. Immunotherapy With Interferon α11, But Not Interferon Beta, Controls Persistent Retroviral Infection.
Schwerdtfeger M; Dickow J; Schmitz Y; Francois S; Karakoese Z; Malyshkina A; Knuschke T; Dittmer U; Sutter K
Front Immunol; 2021; 12():809774. PubMed ID: 35126368
[TBL] [Abstract][Full Text] [Related]
5. Distinct roles of NK cells in viral immunity during different phases of acute Friend retrovirus infection.
Littwitz E; Francois S; Dittmer U; Gibbert K
Retrovirology; 2013 Nov; 10():127. PubMed ID: 24182203
[TBL] [Abstract][Full Text] [Related]
6. Dose of Retroviral Infection Determines Induction of Antiviral NK Cell Responses.
Littwitz-Salomon E; Schimmer S; Dittmer U
J Virol; 2017 Nov; 91(22):. PubMed ID: 28904191
[TBL] [Abstract][Full Text] [Related]
7. Insights into Sensing of Murine Retroviruses.
Moran EA; Ross SR
Viruses; 2020 Jul; 12(8):. PubMed ID: 32751803
[TBL] [Abstract][Full Text] [Related]
8. Negative selection by an endogenous retrovirus promotes a higher-avidity CD4+ T cell response to retroviral infection.
Young GR; Ploquin MJ; Eksmond U; Wadwa M; Stoye JP; Kassiotis G
PLoS Pathog; 2012; 8(5):e1002709. PubMed ID: 22589728
[TBL] [Abstract][Full Text] [Related]
9. Distinct roles of CD4+ T cell subpopulations in retroviral immunity: lessons from the Friend virus mouse model.
Nair S; Bayer W; Ploquin MJ; Kassiotis G; Hasenkrug KJ; Dittmer U
Retrovirology; 2011 Sep; 8():76. PubMed ID: 21943070
[TBL] [Abstract][Full Text] [Related]
10. Systemic Expression of a Viral RdRP Protects against Retrovirus Infection and Disease.
Miller CM; Barrett BS; Chen J; Morrison JH; Radomile C; Santiago ML; Poeschla EM
J Virol; 2020 Apr; 94(9):. PubMed ID: 32051266
[TBL] [Abstract][Full Text] [Related]
11. Retroviral immunology: lessons from a mouse model.
Myers L; Hasenkrug KJ
Immunol Res; 2009; 43(1-3):160-6. PubMed ID: 18830572
[TBL] [Abstract][Full Text] [Related]
12. Negative impact of IFN-γ on early host immune responses to retroviral infection.
Duley AK; Ploquin MJ; Eksmond U; Ammann CG; Messer RJ; Myers L; Hasenkrug KJ; Kassiotis G
J Immunol; 2012 Sep; 189(5):2521-9. PubMed ID: 22821964
[TBL] [Abstract][Full Text] [Related]
13. Humoral immunity in the Friend retrovirus infection model.
Halemano K; Harper MS; Guo K; Li SX; Heilman KJ; Barrett BS; Santiago ML
Immunol Res; 2013 Mar; 55(1-3):249-60. PubMed ID: 22961660
[TBL] [Abstract][Full Text] [Related]
14. Immune control and prevention of chronic Friend retrovirus infection.
Hasenkrug KJ; Dittmer U
Front Biosci; 2007 Jan; 12():1544-51. PubMed ID: 17127401
[TBL] [Abstract][Full Text] [Related]
15. Host genetic factors that control immune responses to retrovirus infections.
Miyazawa M; Tsuji-Kawahara S; Kanari Y
Vaccine; 2008 Jun; 26(24):2981-96. PubMed ID: 18255203
[TBL] [Abstract][Full Text] [Related]
16. Friend retrovirus drives cytotoxic effectors through Toll-like receptor 3.
Gibbert K; Francois S; Sigmund AM; Harper MS; Barrett BS; Kirchning CJ; Lu M; Santiago ML; Dittmer U
Retrovirology; 2014 Dec; 11():126. PubMed ID: 25539593
[TBL] [Abstract][Full Text] [Related]
17. B lymphocyte activation by coinfection prevents immune control of friend virus infection.
Marques R; Antunes I; Eksmond U; Stoye J; Hasenkrug K; Kassiotis G
J Immunol; 2008 Sep; 181(5):3432-40. PubMed ID: 18714015
[TBL] [Abstract][Full Text] [Related]
18. Fv1, the mouse retrovirus resistance gene.
Stoye JP
Rev Sci Tech; 1998 Apr; 17(1):269-77. PubMed ID: 9638816
[TBL] [Abstract][Full Text] [Related]
19. Combination of nanoparticle-based therapeutic vaccination and transient ablation of regulatory T cells enhances anti-viral immunity during chronic retroviral infection.
Knuschke T; Rotan O; Bayer W; Sokolova V; Hansen W; Sparwasser T; Dittmer U; Epple M; Buer J; Westendorf AM
Retrovirology; 2016 Apr; 13():24. PubMed ID: 27076190
[TBL] [Abstract][Full Text] [Related]
20. Polyinosinic-polycytidylic acid treatment of Friend retrovirus-infected mice improves functional properties of virus-specific T cells and prevents virus-induced disease.
Gibbert K; Dietze KK; Zelinskyy G; Lang KS; Barchet W; Kirschning CJ; Dittmer U
J Immunol; 2010 Nov; 185(10):6179-89. PubMed ID: 20943997
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]